Nogo-A functions during the development of the central nervous system and in the adult;Funciones de Nogo-A durante el desarrollo del sistema nervioso central y en el animal adulto

Revista de Neurologia

Volumn 39, Issue 5, 2004, Pages 440-446

  Mingorance, A ^a   Soriano Garcia E ^a   Del Rio J A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Fasciculation; Inhibition; Myelin; NgR; Nogo A; Regeneration

Indexed keywords

MYELIN; PROTEIN NOGO A;

APOPTOSIS; CENTRAL NERVOUS SYSTEM; CLONE; FASCICULATION; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INJURY; OLIGODENDROGLIA; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; REVIEW;

EID: 8144230384     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3905.2004432     Document Type: Review

References (65)

1. Fawcett JW, Asher RA. The glial scar and central nervous system repair. Brain Res Bull 1999; 49: 377-91.
2. Chen MS, Huber AB, Van der Haar ME, Frank M, Schnell L, Spillmann AA, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000; 403: 434-9.
3. GrandPre T, Nakamura F, Vartanian T, Strittmatter SM. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000; 403: 439-44.
4. Prinjha R, Moore SE, Vinson M, Blake S, Morrow R, Christie G, et al. Inhibitor of neurite outgrowth in humans. Nature 2000; 403: 383-4.
5. McKerracher L, David S, Jackson DL, Kottis V, Dunn RJ, Braun PE, et al. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 1994; 13: 805-11.
6. Mukhopadhyay G, Doherty P, Walsh FS, Crocker PR, Filbin MT. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 1994; 13: 757-67.
7. Kottis V, Thibault P, Mikol D, Xiao ZC, Zhang R, Dergham P, et al. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem 2002; 82: 1566-9.
8. Caroni P, Schwab ME. Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading. J Cell Biol 1988; 106: 1281-8.
9. Caroni P, Schwab ME. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 1988; 1: 85-96.
10. Schnell L, Schwab ME. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 1990; 343: 269-72.
11. Bregman BS, Kunkel-Bagden E, Schnell L, Dai HN, Gao D, Schwab ME. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 1995; 378: 498-501.
12. Thallmair M, Metz GA, Z'Graggen WJ, Raineteau O, Kartje GL, Schwab ME. Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions. Nat Neurosci 1998; 1: 124-31.
13. Oertle T, Klinger M, Stuermer CA, Schwab ME. A reticular rhapsody: phylogenic evolution and nomenclature of the RTN/Nogo gene family. Faseb J 2003; 17: 1238-47.
14. Oertle T, Schwab ME. Nogo and its partners. Trends Cell Biol 2003; 13: 187-94.
15. Josephson A, Widenfalk J, Widmer HW, Olson L, Spenger C. NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury. Exp Neurol 2001; 169: 319-28.
16. Huber AB, Schwab ME. Nogo-A, a potent inhibitor of neurite outgrowth and regeneration. Biol Chem 2000; 381: 407-19.
17. Tozaki H, Kawasaki T, Takagi Y, Hirata T. Expression of Nogo protein by growing axons in the developing nervous system. Brain Res Mol Brain Res 2002; 104: 111-9.
18. Mingorance A, Fontana X, Sole M, Burgaya F, Urena JM, Teng FY, et al. Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions. Mol Cell Neurosci 2004; 26: 34-49.
19. Oertle T, Van der Haar ME, Bandtlow CE, Robeva A, Burfeind P, Buss A, et al. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci 2003; 23: 5393-406.
20. Fournier AE, GrandPre T, Strittmatter SM. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 2001; 409: 341-6.
21. Hunt D, Mason MR, Campbell G, Coffin R, Anderson PN. Nogo receptor mRNA expression in intact and regenerating CNS neurons. Mol Cell Neurosci 2002; 20: 537-52.
22. Nie DY, Zhou ZH, Ang BT, Teng FY, Xu G, Xiang T, et al. Nogo-A at CNS paranodes is a ligand of Caspr: possible regulation of K(+) channel localization. Embo J 2003; 22: 5666-78.
23. Li Q, Qi B, Oka K, Shimakage M, Yoshioka N, Inoue H, et al. Link of a new type of apoptosis-inducing gene ASY/Nogo-B to human cancer. Oncogene 2001; 20: 3929-36.
24. Watari A, Yutsudo M. Multi-functional gene ASY/Nogo/RTN-X/RTN4: apoptosis, tumor suppression, and inhibition of neuronal regeneration. Apoptosis 2003; 8: 5-9.
25. Hu WH, Hausmann ON, Yan MS, Walters WM, Wong PK, Bethea JR. Identification and characterization of a novel Nogo-interacting mitochondrial protein (NIMP). J Neurochem 2002; 81: 36-45.
26. Taketomi M, Kinoshita N, Kimura K, Kitada M, Noda T, Asou H, et al. Nogo-A expression in mature oligodendrocytes of rat spinal cord in association with specific molecules. Neurosci Lett 2002; 332: 37-40.
27. Steiner P, Kulangara K, Sarria JC, Glauser L, Regazzi R, Hirling H. Reticulon 1-C/neuroendocrine-specific protein-C interacts with SNARE proteins. J Neurochem 2004; 89: 569-80.
28. Xiao ZC, Revest JM, Laeng P, Rougon G, Schachner M, Montag D. Defasciculation of neurites is mediated by tenascin-R and its neuronal receptor F3/11. J Neurosci Res 1998; 52: 390-404.
29. Falk J, Bonnon C, Girault JA, Faivre-Sarrailh C. F3/contactin, a neuronal cell adhesion molecule implicated in axogenesis and myelination. Biol Cell 2002; 94: 327-34.
30. Fournier AE, GrandPre T, Gould G, Wang X, Strittmatter SM. Nogo and the Nogo-66 receptor. Prog Brain Res 2002; 137: 361-9.
31. Schwab ME. Nogo and axon regeneration. Curr Opin Neurobiol 2004; 14: 118-24.
32. Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 2002; 417: 941-4.
33. Liu BP, Fournier A, GrandPre T, Strittmatter SM. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 2002; 297: 1190-3.
34. Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E, et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 2002; 35: 283-90.
35. Yamashita T, Higuchi H, Tohyama M. The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J Cell Biol 2002; 157: 565-70.
36. Wong ST, Henley JR, Kanning KC, Huang KH, Bothwell M, Poo MM. A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci 2002; 5: 1302-8.
37. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 2004; 7: 221-8.
38. Niederost B, Oertle T, Pritsche J, McKinney RA, Bandtlow CE. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Racl. J Neurosci 2002; 22: 10368-76.
39. Gallo G, Letourneau PC. Regulation of growth cone actin filaments by guidance cues. J Neurobiol 2004; 58: 92-102.
40. Yamashita T, Tohyama M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat Neurosci 2003; 6: 461-7.
41. Sivasankaran R, Pei J, Wang KC, Zhang YP, Shields CB, Xu XM, et al. PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration. Nat Neurosci 2004; 7: 261-8.
42. Cai D, Shen Y, De Bellard M, Tang S, Filbin MT. Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. Neuron 1999; 22: 89-101.
43. Cai D, Qiu J, Cao Z, McAtee M, Bregman BS, Filbin MT. Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J Neurosci 2001; 21: 4731-9.
44. Qiu J, Cai D, Dai H, McAtee M, Hoffman PN, Bregman BS, et al. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron 2002; 34: 895-903.
45. Kim JE, Li S, GrandPre T, Qiu D, Strittmatter SM. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 2003; 38: 187-99.
46. Simonen M, Pedersen V, Weinmann O, Schnell L, Buss A, Ledermann B, et al. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 2003; 38: 201-11.
47. Zheng B, Ho C, Li S, Keirstead H, Steward O, Tessier-Lavigne M. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron 2003; 38: 213-24.
48. Kim JE, Liu BP, Yang X, Strittmatter SM. Recovery from spinal cord injury in mice lacking the nogo-66 receptor. Program No. 415.11. 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience; 2003 [on line]. URL: http://sfn.scholarone.com/itin2003/index.html.
49. Woolf CJ. No Nogo: now where to go? Neuron 2003; 38: 153-6.
50. Fiedler M, Horn C, Bandtlow C, Schwab ME, Skerra A. An engineered IN-1 F(ab) fragment with improved affinity for the Nogo-A axonal growth inhibitor permits immunochemical detection and shows enhanced neutralizing activity. Protein Eng 2002; 15: 931-41.
51. Raineteau O, Fouad K, Noth P, Thallmair M, Schwab ME. Functional switch between motor tracts in the presence of the mAb IN-1 in the adult rat. Proc Natl Acad Sci USA 2001; 98: 6929-34.
52. Von Meyenburg J, Brosamle C, Metz GA, Schwab ME. Regeneration and sprouting of chronically injured corticospinal tract fibers in adult rats promoted by NT-3 and the mAb IN-1, which neutralizes myelin-associated neurite growth inhibitors. Exp Neurol 1998; 154: 583-94.
53. Merkler D, Metz GA, Raineteau O, Dietz V, Schwab ME, Fouad K. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J Neurosci 2001; 21: 3665-73.
54. Wenk CA, Thallmair M, Kartje GL, Schwab ME. Increased corticofugal plasticity after unilateral cortical lesions combined with neutralization of the IN-1 antigen in adult rats. J Comp Neurol 1999; 410: 143-57.
55. Z'Graggen WJ, Metz GA, Kartje GL, Thallmair M, Schwab ME. Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockade of myelin-associated neurite growth inhibitors in adult rats. J Neurosci 1998; 18: 4744-57.
56. Cadelli D, Schwab ME. Regeneration of lesioned septohippocampal acetylcholinesterase-positive axons is improved by antibodies against the myelin-associated neurite growth inhibitors NI-35/250. Eur J Neurosci 1991; 3: 825-32.
57. Tatagiba M, Rosahl S, Gharabaghi A, Blomer U, Brandis A, Skerra A, et al. Regeneration of auditory nerve following complete sectioning and intrathecal application of the IN-1 antibody. Acta Neurochir (Wien) 2002; 144: 181-7.
58. GrandPre T, Li S, Strittmatter SM. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 2002; 417: 547-51.
59. Li S, Strittmatter SM. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J Neurosci 2003; 23: 4219-27.
60. Huang DW, McKerracher L, Braun PE, David S. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron 1999; 24: 639-47.
61. Hauben E, Ibarra A, Mizrahi T, Barouch R, Agranov E, Schwartz M. Vaccination with a Nogo-A-derived peptide after incomplete spinalcord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens. Proc Natl Acad Sci USA 2001; 98: 15173-8.
62. Sicotte M, Tsatas O, Jeong SY, Cai CQ, He Z, David S. Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord. Mol Cell Neurosci 2003; 23: 251-63.
63. Steinman L, Martin R, Bernard C, Conlon P, Oksenberg JR. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu Rev Neurosci 2002; 25: 491-505.
64. Karnezis T, Mandemakers W, McQualter JL, Zheng B, Ho PP, Jordan KA, et al. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat Neurosci 2004; 7: 736-44.
65. Martínez A, Otal R, Soriano-García E. Efrinas, desarrollo neuronal y plasticidad. Rev Neurol 2004; 38: 647-55.